Ocular Therapeutix OCUL Business Segments — Other Nonoperating Items

Similar metrics at other companies

SRRKSingle Reportable — Other Nonoperating Income Expense

$3.49M+248%

QURESingle Reportable — Other Nonoperating Income Expense

$199K-96.1%

MCRISingle Reportable — Other Nonoperating Income Expense

-$598K-89.2%

EWTXSingle Reportable — Other Nonoperating Income

$5.9M-5.6%

ONTOSingle Reportable — Other Nonoperating Income Expense

-$1.25M-3,346%

POWISingle Reportable — Other Operating Income Expense Net

$0—

Questions, answered.

What is Ocular Therapeutix's business segments — other nonoperating items?

Ocular Therapeutix (OCUL) reported business segments — other nonoperating items of $1.46M in Q1 2026.

How has Ocular Therapeutix's business segments — other nonoperating items changed year-over-year?

Ocular Therapeutix's business segments — other nonoperating items increased by 248.8% year-over-year, from -$978K to $1.46M.

What is the long-term trend for Ocular Therapeutix's business segments — other nonoperating items?

Over 2 years (2022 to 2024), Ocular Therapeutix's business segments — other nonoperating items has grown at a 43.3% compound annual growth rate (CAGR), from $13.84M to -$28.43M.

What does business segments — other nonoperating items mean?

This captures miscellaneous gains or losses that fall outside the company's primary business activities, such as foreign exchange fluctuations, litigation settlements, or asset disposals. It provides visibility into peripheral financial events that impact the bottom line but are not indicative of core operational performance. Investors track this to isolate the impact of non-recurring or non-core events on net income.